ProfileGDS4718 / 1562655_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 14% 20% 19% 23% 14% 20% 13% 16% 14% 23% 23% 21% 18% 13% 19% 21% 17% 16% 19% 11% 28% 15% 18% 17% 17% 19% 15% 19% 21% 14% 22% 16% 17% 18% 11% 14% 14% 15% 16% 24% 19% 18% 14% 11% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.931514
GSM549102patient 115, normal, homogenized [OPG study]4.1514220
GSM549104patient 119, normal, homogenized [OPG study]4.0730719
GSM549108patient 138, normal, homogenized [OPG study]4.3116323
GSM549119patient 077, normal, homogenized [OPG study]3.9415214
GSM549133patient 032, cancer, homogenized [OPG study]4.1022620
GSM549139patient 042, cancer, homogenized [OPG study]3.8830413
GSM549099patient 107, normal, homogenized [OPG study]4.0262716
GSM549109patient 139, normal, homogenized [OPG study]3.9345814
GSM549110patient 046, normal, homogenized [OPG study]4.2452523
GSM549114patient 063, normal, homogenized [OPG study]4.2266423
GSM549122patient 082, normal, homogenized [OPG study]4.2051721
GSM549134patient 033, cancer, homogenized [OPG study]4.0740818
GSM549136patient 036, cancer, homogenized [OPG study]3.8557713
GSM549140patient 044, cancer, homogenized [OPG study]4.0858719
GSM549111patient 047, normal, homogenized [OPG study]4.1718821
GSM549113patient 057, normal, homogenized [OPG study]4.0014717
GSM549132patient 031, cancer, homogenized [OPG study]3.9813716
GSM549137patient 038, cancer, homogenized [OPG study]4.0898319
GSM549142patient 047, cancer, homogenized [OPG study]3.879411
GSM549100patient 110, normal, homogenized [OPG study]4.496228
GSM549107patient 135, normal, homogenized [OPG study]3.9371215
GSM549115patient 068, normal, homogenized [OPG study]4.0185218
GSM549116patient 072, normal, homogenized [OPG study]4.0195817
GSM549120patient 078, normal, homogenized [OPG study]4.0125317
GSM549131patient 030, cancer, homogenized [OPG study]4.0499719
GSM549118patient 074, normal, homogenized [OPG study]3.9769615
GSM549129patient 027, cancer, homogenized [OPG study]4.12719
GSM549123patient 088, normal, homogenized [OPG study]4.168221
GSM549124patient 006, cancer, homogenized [OPG study]3.96714
GSM549126patient 015, cancer, homogenized [OPG study]4.2229322
GSM549128patient 025, cancer, homogenized [OPG study]3.9860816
GSM549103patient 117, normal, homogenized [OPG study]4.0544517
GSM549117patient 073, normal, homogenized [OPG study]4.0472418
GSM549138patient 041, cancer, homogenized [OPG study]3.7893411
GSM549141patient 045, cancer, homogenized [OPG study]3.859914
GSM549130patient 028, cancer, homogenized [OPG study]3.9308414
GSM549101patient 111, normal, homogenized [OPG study]3.9655215
GSM549105patient 128, normal, homogenized [OPG study]3.9997716
GSM549106patient 134, normal, homogenized [OPG study]4.255724
GSM549112patient 048, normal, homogenized [OPG study]4.1191419
GSM549125patient 011, cancer, homogenized [OPG study]4.0648818
GSM549127patient 024, cancer, homogenized [OPG study]3.9059214
GSM549135patient 035, cancer, homogenized [OPG study]3.7873411